Cargando…
High‐ and low‐molecular‐weight chitosan act as adjuvants during single‐dose influenza A virus protein vaccination through distinct mechanisms
The investigation of new adjuvants is essential for the development of efficacious vaccines. Chitosan (CS), a derivative of chitin, has been shown to act as an adjuvant, improving vaccine‐induced immune responses. However, the effect of CS molecular weight (MW) on this adjuvanticity has not been inv...
Autores principales: | Lampe, Anna T., Farris, Eric J., Brown, Deborah M., Pannier, Angela K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897297/ https://www.ncbi.nlm.nih.gov/pubmed/33289090 http://dx.doi.org/10.1002/bit.27647 |
Ejemplares similares
-
AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB/c Mice
por: Yam, Karen K., et al.
Publicado: (2015) -
1237. Robust Adjuvant Activity and Dose-sparing Potential of the Novel Semisynthetic Saponin Adjuvant TQL1055 for Seasonal and Pandemic Influenza
por: Buzz, Chloe, et al.
Publicado: (2020) -
Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children
por: Van Buynder, P. G., et al.
Publicado: (2010) -
Adjuvanted influenza vaccine dynamics
por: Parra-Rojas, César, et al.
Publicado: (2019) -
Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)